rs371394378

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_031206.7(LAS1L):​c.1892G>C​(p.Gly631Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000488 in 1,208,726 control chromosomes in the GnomAD database, including 1 homozygotes. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G631G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.000050 ( 1 hom. 15 hem. )

Consequence

LAS1L
NM_031206.7 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.55

Publications

1 publications found
Variant links:
Genes affected
LAS1L (HGNC:25726): (LAS1 like ribosome biogenesis factor) Enables RNA binding activity. Predicted to be involved in maturation of 5.8S rRNA and maturation of LSU-rRNA. Located in membrane. Part of MLL1 complex. Implicated in Wilson-Turner syndrome. [provided by Alliance of Genome Resources, Apr 2022]
LAS1L Gene-Disease associations (from GenCC):
  • Wilson-Turner syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P
  • spinal muscular atrophy with respiratory distress type 2
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.047071785).
BS2
High Hemizygotes in GnomAdExome4 at 15 Unknown,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAS1LNM_031206.7 linkc.1892G>C p.Gly631Ala missense_variant Exon 12 of 14 ENST00000374811.8 NP_112483.1 Q9Y4W2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAS1LENST00000374811.8 linkc.1892G>C p.Gly631Ala missense_variant Exon 12 of 14 1 NM_031206.7 ENSP00000363944.3 Q9Y4W2-1

Frequencies

GnomAD3 genomes
AF:
0.0000355
AC:
4
AN:
112632
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000751
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000170
AC:
3
AN:
176921
AF XY:
0.0000317
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000384
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000502
AC:
55
AN:
1096094
Hom.:
1
Cov.:
31
AF XY:
0.0000415
AC XY:
15
AN XY:
361832
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26245
American (AMR)
AF:
0.00
AC:
0
AN:
34961
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19194
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30199
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53733
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40471
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4114
European-Non Finnish (NFE)
AF:
0.0000618
AC:
52
AN:
841193
Other (OTH)
AF:
0.0000652
AC:
3
AN:
45984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000355
AC:
4
AN:
112632
Hom.:
0
Cov.:
24
AF XY:
0.0000287
AC XY:
1
AN XY:
34786
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31032
American (AMR)
AF:
0.00
AC:
0
AN:
10695
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3592
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2737
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6217
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000751
AC:
4
AN:
53259
Other (OTH)
AF:
0.00
AC:
0
AN:
1527
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 02, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1892G>C (p.G631A) alteration is located in exon 12 (coding exon 12) of the LAS1L gene. This alteration results from a G to C substitution at nucleotide position 1892, causing the glycine (G) at amino acid position 631 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Wilson-Turner syndrome Uncertain:1
Jun 20, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 631 of the LAS1L protein (p.Gly631Ala). This variant is present in population databases (rs371394378, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with LAS1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 464823). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
14
DANN
Benign
0.27
DEOGEN2
Benign
0.021
.;T;.
FATHMM_MKL
Benign
0.55
D
LIST_S2
Benign
0.83
T;T;T
M_CAP
Benign
0.064
D
MetaRNN
Benign
0.047
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.85
.;L;.
PhyloP100
1.6
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.20
N;N;N
REVEL
Benign
0.047
Sift
Benign
1.0
T;T;T
Sift4G
Benign
0.96
T;T;T
Polyphen
0.063
B;B;B
Vest4
0.10
MutPred
0.15
.;Gain of helix (P = 0.0117);.;
MVP
0.48
MPC
0.69
ClinPred
0.038
T
GERP RS
2.6
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
3.9
Varity_R
0.050
gMVP
0.086
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371394378; hg19: chrX-64737902; API